Why is APO tanking? It's rated buy by a lot of analysts, it's in a growth industry with digital conversions and it's revenue is reliable. Not happy.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%